会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • METHODS AND COMPOSITIONS FOR LONG TERM HEMATOPOIETIC REPOPULATION
    • 长期HEMATOPOIETIC REPOPULATION的方法和组合
    • US20120114614A1
    • 2012-05-10
    • US13129359
    • 2009-11-16
    • Janina RatajczakEwa K. Zuba-SurmaMariusz Ratajczak
    • Janina RatajczakEwa K. Zuba-SurmaMariusz Ratajczak
    • A61K35/12A61N5/00C12N5/02C12N5/078C12N5/07
    • A61K35/28A61K35/51A61K2035/124C12N5/0647C12N5/0665C12N2502/1335C12N2502/1394
    • Methods for isolating a CD133+/CD45neg/GlyAneg subpopulation of umbilical cord blood cells are disclosed. In some embodiments, the methods include providing an initial population of umbilical cord blood cells; contacting the initial population of cells with a first antibody that is specific for CD133, a second antibody that is specific for CD45, and a third antibody that is specific for Glycophorin A (GIyA) under conditions sufficient to allow binding of each antibody to its target, if present, on each cell of the initial population of cells; and isolating a subpopulation of cells that are CD133+, CD45neg, and GlyAneg. Also provided are isolated populations of CD133+/GlyAneg/CD45neg stem cells isolated from cord blood, methods for repopulating cell types in subjects, methods for bone marrow transplantation, methods for inducing hematopoietic competency in CD133+/GlyAneg/CD45neg stem cells, and cell culture systems that include CD133+/GIyAneg/CD45neg stem cells.
    • 公开了分离脐带血细胞的CD133 + / CD45neg / GlyAneg亚群的方法。 在一些实施方案中,所述方法包括提供脐带血细胞的初始群体; 使初始细胞群与第一抗体CD133特异性接触,第二抗体是CD45特异性的第二抗体,以及在足以允许每种抗体与靶标结合的条件下对Glycophorin A(Gly)特异性的第三抗体 如果存在,则在初始细胞群体的每个细胞上; 并分离CD133 +,CD45neg和GlyAneg细胞亚群。 还提供了从脐带血分离的CD133 + / GlyAneg / CD45neg干细胞的分离群体,用于重新培养受试者中的细胞类型的方法,用于骨髓移植的方法,在CD133 + / GlyAneg / CD45neg干细胞中诱导造血能力的方法和细胞培养系统 其包括CD133 + / GlyYneg / CD45neg干细胞。